Larimar Therapeutics, Inc. (LRMR) › Total LiabilitiesLarimar Therapeutics, Inc. (LRMR) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2013: $2.92M2014: $13.08M2015: $20.00M2016: $9.89M2017: $27.29M2018: $28.49M2019: $5.89M2020: $14.99M2021: $14.25M2022: $15.50M2023: $14.21M2024: $28.41M2025: $67.76M$67.76M2013Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$67.76M+138.5%2024$28.41M+99.9%2023$14.21M-8.3%2022$15.50M+8.8%2021$14.25M-4.9%2020$14.99M+154.4%2019$5.89M-79.3%2018$28.49M+4.4%2017$27.29M+175.9%2016$9.89M-50.5%2015$20.00M+52.9%2014$13.08M+348.6%2013$2.92M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share